Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Clinical trial NCT07073755 · RECRUITING

Trial details

NCT number: NCT07073755
Sponsor: Hunan Cancer Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Breast Cancer Drug Resistance Hormone Receptor-Positive Breast Cancer HER2-positive Breast Cancer Triple-Negative Breast Cancer (TNBC)Treatment Decisions

Start date: 2023-01-01
Primary completion: 2025-12-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.